Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Blood (2024) 144 (Supplement 1): 6718.

https://doi.org/10.1182/blood-2024-209513

Published: 2024

Journal Articles

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Blood (2023) 142 (Supplement 1): 5179.

https://doi.org/10.1182/blood-2023-185122

Published: 2023

Journal Articles

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Sofia Grille, Elvira DRP Velloso, Matilde Boada, Elia Apodaca Chavez, Andres Gomez-De Leon, Anna Cecilia Rodríguez-Zuñiga, Emmanuel Martínez Moreno, Fernando Perez-Jacobo, Graciela Alfonso, Juan Carlos Serrano, Natalia Tejeira, Lilián Díaz, Valentina Olivares, Laura Kornblihtt, Sergio Schusterschitz, Marcelo Iastrebner

Blood (2022) 140 (Supplement 1): 4096–4097.

https://doi.org/10.1182/blood-2022-168893

Published: 2022

Journal Articles

Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Marcelo Iastrebner, Renee Leonor Crisp, Roberto Ovilla, Andres Gomez-De Leon, Adriana Karola Puente, Fernando Barroso Duarte, Elvira DRP Velloso, Breno Gusmao, Ana Varela, Matilde Boada, Sofia Grille

Blood (2022) 140 (Supplement 1): 12329–12330.

https://doi.org/10.1182/blood-2022-163174

Published: 2022

Journal Articles

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Roberto Ovilla, MD, Renee Leonor Crisp, PhD, Pamela E Baez-Islas, MD, Jorge A Arbelbide, MD, Sofia Grille, MD PhD, Lilián Díaz, MD, Henry Idrobo, MD Professor, Alicia Enrico, MD, Maria J Mela Osorio, MD, Isolda I. Fernandez, MD, Luciana C Ferrari, MD, Nidia Zapata, MD, Adrian A Ceballos-Lopez, Veronica Mena, MD, Ana L Romero, MD, Juan Carlos Serrano, MD, Gabriela Vidal-Senmache, MD, Fernando Barroso Duarte, MD, Edit N Pintos, MD, Mariana Rosenhain, MD, Laura Kornblihtt, MD, Natalia Tejeira, MD, Breno Gusmao, MD, Maria Elena Del Rocio Buenaño, MD, Marcos Di Stefano, MD, Matilde Boada, MD, Alberto Gimenez Conca, MD, Maria Perusini, MD, Hernan Dick, MD, Santiago Cranco, MD, Maria Lucia Fuente, Alicia Beatriz Navickas, MD, Maria M Moirano, MD, Natalia Oliveira, MD, Jacqueline Gonzalez, MD, Mariana Bandín, MD, Noelia Villaverde, MD, Alejandro Suero, MD, Juan Felipe Lasso, MD, Nora Carrara, MD, Xochitl Cota, MD, Carolina Lazzarino, MD, Maria Leticia Rapan, MD, Marcelo Iastrebner, MD, Latin-American MDS Group (GLAM), MDS and Acute Leukemia Sub-Commission Group Argentinian Society of Hematology

Blood (2019) 134 (Supplement_1): 5096.

https://doi.org/10.1182/blood-2019-125311

Published: 2019

Journal Articles

Implementation of a Cardio Oncology Protocol in Uruguay

Pía Oldan, MD, Andreina Gomez, MD, Gabriel Parma, MD, Cecilia Guillermo, MD, Lilián Díaz, MD, Matilde Boada, MD MSc

Blood (2019) 134 (Supplement_1): 5888.

https://doi.org/10.1182/blood-2019-127068

Published: 2019

NARROW

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Implementation of a Cardio Oncology Protocol in Uruguay

Email alerts

ASH Publications

American Society of Hematology

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Implementation of a Cardio Oncology Protocol in Uruguay

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only